Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inari Medical Inc
(NQ:
NARI
)
42.03
+0.04 (+0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,060,841
Open
42.45
Bid (Size)
41.00 (1)
Ask (Size)
44.83 (1)
Prev. Close
41.99
Today's Range
41.07 - 42.77
52wk Range
36.81 - 71.85
Shares Outstanding
54,313,676
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
May 03, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 01, 2024
Via
Benzinga
Performance
YTD
-36.09%
-36.09%
1 Month
-0.73%
-0.73%
3 Month
-25.23%
-25.23%
6 Month
-20.02%
-20.02%
1 Year
-34.77%
-34.77%
More News
Read More
What 8 Analyst Ratings Have To Say About Inari Medical
April 12, 2024
Via
Benzinga
Forecasting The Future: 7 Analyst Projections For Inari Medical
March 22, 2024
Via
Benzinga
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
May 01, 2024
Via
Benzinga
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
May 01, 2024
Via
Benzinga
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024
April 30, 2024
Via
InvestorPlace
Inari Medical Reports First Quarter 2024 Financial Results
April 30, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 22, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 19, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical to Announce First Quarter 2024 Financial Results
April 17, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 15, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
April 11, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 11, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
April 02, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Market Cap Game Show: Andy Cross vs. Bill Mann
March 30, 2024
Via
The Motley Fool
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 18, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 18, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 17, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 17, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
March 16, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.